Jazz Pharma Reports Pro Forma Epidiolex Sales Grew 32% to $156 Million in Q2
As Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals says: “We have now executed four of five planned product launches since the beginning… Read More »Jazz Pharma Reports Pro Forma Epidiolex Sales Grew 32% to $156 Million in Q2